Active-ingredient Dossier
Modafinil
Active-ingredient Dossier for Modafinil (wakefulness-promoting agent). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: MODAFIN
- Brand: APO-MODAFINIL
- Brand: MODAFINIL
- Brand: MODAFINIL
- Brand: MODAFINIL-WGR
- Brand: MFINIL
- Therapeutic area: Neurology
- Therapeutic area: Psychiatry
What is
Modafinil Modafinil is a wakefulness-promoting agent.
Australian brands containing
Modafinil — MODAFIN — MODAVIGIL — APO-MODAFINIL — MODAFINIL — MODAFINIL-WGR — MFINIL
Therapeutic areas
Modafinil is registered in neurology, with 14 brands containing this ingredient on the ARTG.
Sponsor landscape
Modafinil is marketed by six sponsors: Arrotex Pharmaceuticals, Southern Cross Pharma, Helix Pharmaceuticals, Teva Pharma, GM Pharma, and Neuraxpharm.
PBS and regulatory activity
One brand containing modafinil has PBS-listed items, with the latest PBS schedule date being 1 May 2026. The latest PBAC outcome on record is from 1 July 2020, with one brand having PBAC outcomes recorded and no brands with AusPARs on record.